3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Magnetic Resonance Spectroscopy
6
Radiotherapy
4
Biopsy
4
Radiotherapy, Intensity-Modulated
3
Cisplatin
3
Blood Specimen Collection
3
Narrow Band Imaging
2
Mohs Surgery
2
Fluorouracil
2
Esophagectomy
2
pembrolizumab
1
fluoromisonidazole
1
dacomitinib
1
bintrafusp alfa protein, human
1
Vitamin D
1
Surveys and Questionnaires
1
Standard of Care
1
Sentinel Lymph Node Biopsy
1
Second Harmonic Generation Microscopy
1
Risk Factors
1
Ribavirin
1
Radiosurgery
1
Protons
1
Proflavine
1
Pressure
1
Photochemotherapy
1
Phlebotomy
1
Paclitaxel
1
Observation
1
Nimorazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Carcinoma, Squamous Cell
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled